Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
159.7 USD | +0.03% | -5.03% | +2.89% |
05:26pm | BMO Capital Cuts Price Target on AbbVie to $180 From $195, Maintains Outperform Rating | MT |
02:52pm | Morgan Stanley Adjusts AbbVie's Price Target to $191 From $196 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.87% | 283B | |
+25.34% | 661B | |
+26.74% | 566B | |
-6.59% | 352B | |
+20.30% | 332B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-5.11% | 145B | |
-10.56% | 144B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Transcript : AbbVie Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 09